RSS Feeds
Erythropoietin, Gadolinium, and Nephrogenic Fibrosing Dermopathy
- Nelson Leung, MD;
- Sundararaman Swaminathan, MBBS;
- Iftikhar Ahmed, MD;
- James T. McCarthy, MD;
- Robert C. Albright, DO;
- Mark R. Pittelkow, MD;
- Noel M. Caplice, MD, PhD; and
- Matthew D. Griffin, MB BCh
- From Mayo Clinic College of Medicine, Rochester, Minnesota.
IN RESPONSE:
We appreciate Dr. Hellman's interest and comments. We, too, have noted that nearly half of our patients with nephrogenic fibrosing dermopathy had gadolinium exposure before …
This 100-word excerpt has been provided in the absence of an abstract.
